glp 1 drug coverage Comparing Ozempic, Wegovy and Other GLP-1 Drugs Paving the way for expanded
Description
Unfortunately, the surge in use of these drugs has also translated into a huge increase in accidental overdoses
However, safety and efficacy data in pregnancy remain limited
Meta-Analyses and Real-World Evidence A 2021 meta-analysis of major CVOTs confirmed a 14% MACE reduction (HR 0.86, 95% CI 0.80-0.93) with GLP-1 agonists, with significant reductions in MI, stroke, cardiovascular death, and all-cause mortality [51]
Chang, M
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals
European Journal of Endocrinology
